Product Information MARINOL® is a unique prescription medicine that relieves multiple symptoms.  The United States Food and Drug Administration (FDA) approved MARINOL® to treat nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional treatments. The FDA also approved MARINOL® to treat appetite loss associated with weight loss in people with AIDS.  Health care professionals may prescribe MARINOL® to help stimulate an HIV/AIDS patient’s appetite so he or she will want to eat again. MARINOL® is a synthetic version of a naturally occurring compound known as delta-9-THC.  Delta-9-THC stimulates appetite and reduces nausea and vomiting by binding to special receptors found in the nervous system. MARINOL® is contraindicated in any patient who has a history of hypersensitivity to any cannabinoid or sesame oil. Patients should be warned not to drive, operate machinery, or engage in hazardous activity until they establish they can tolerate MARINOL®  and perform such tasks safely. A cannabinoid dose-related “high” (easy laughing, elation and heightened awareness) has been reported by patients receiving MARINOL® in both the antiemetic (24%) and the lower dose appetite stimulant clinical trials (8%).  Other frequently reported adverse events in MARINOL® clinical trials included abdominal pain, nausea, vomiting, dizziness, euphoria, paranoid reaction, somnolence, and thinking abnormal.    MARINOL® Prescribing and Safety Information Additional Information MARINOL® is available by prescription only.  Ask your doctor if MARINOL® is right for you.  For more information about MARINOL® please visit www.marinol.com.